The Impact of Genetic Factors on the Development of Type 2 Diabetes and Possible Pathways for its Correction
Acta medica Lituanica · 23.07.2026 · 33 (2) · 8
DOI: 10.15388/amed.2026.33.2.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta medica Lituanica, online erschienen am 23.07.2026. Verfasst von Zhibek Sembayeva und 4 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
The aim of this study was to investigate the impact of genetic factors on the development of type 2 diabetes in the population of Kazakhstan. Materials and methods: The methodology included the collection of demographic data, the analysis of biochemical parameters, and the application of polymerase chain reaction genotyping for single-nucleotide polymorphisms in genes associated with type 2 diabetes.
Result
The main results of the study demonstrated that patients with type 2 diabetes had a 20% higher body mass index (29.5±4.2 kg/m2 versus 24.3±3.1 kg/m2) and 29% lower physical activity (3.2±1.5 hours per week versus 4.5±2.0 hours per week) compared with the control group. Biochemical parameters showed a 50% higher glucose level (7.8±2.1 mmol/L versus 5.2 ± 0.8 mmol/L), insulin levels by 76% (15.3±5.2 microunits per millilitre versus 8.7±2.5 microunits per millilitre), and glycated haemoglobin by 42% (7.5±1.2% versus 5.3±0.5%) in patients with type 2 diabetes. The genetic analysis revealed substantial associations between type 2 diabetes and risk alleles in the TCF7L2 (rs7903146), KCNJ11 (rs5219), FTO (rs9939609), PPARG (rs1801282), and ADIPOQ (rs1501299) genes, which were linked to compromised insulin secretion and metabolic anomalies in the study population.
Conclusions
The practical significance of the study lies in the potential application of these findings to develop personalised approaches for the prevention and treatment of type 2 diabetes, including lifestyle modification, the use of modern pharmaceuticals, and anti-inflammatory drugs to improve glucose control in patients.
Zitieren
APA
Sembayeva, Z., Ilderbayev, O., Tazhibayeva, D., Zhanilova, A., & Ilderbayeva, A. (2026). The Impact of Genetic Factors on the Development of Type 2 Diabetes and Possible Pathways for its Correction. Acta medica Lituanica, 33(2), 8. https://doi.org/10.15388/amed.2026.33.2.8
Vancouver
Sembayeva Z, Ilderbayev O, Tazhibayeva D, Zhanilova A, Ilderbayeva A. The Impact of Genetic Factors on the Development of Type 2 Diabetes and Possible Pathways for its Correction. Acta medica Lituanica. 2026;33(2):8. doi:10.15388/amed.2026.33.2.8
BibTeX
@article{Sembayeva2026,
author = {Sembayeva, Zhibek and Ilderbayev, Oralbek and Tazhibayeva, Damira and Zhanilova, Ainur and Ilderbayeva, Aruzhan},
title = {The Impact of Genetic Factors on the Development of Type 2 Diabetes and Possible Pathways for its Correction},
journal = {Acta medica Lituanica},
year = {2026},
volume = {33},
number = {2},
pages = {8},
doi = {10.15388/amed.2026.33.2.8}
}
EUVIMED